{"id":"https://openalex.org/W2530856490","doi":"https://doi.org/10.1182/blood.v112.11.5034.5034","title":"Multiple Strategies Based on MEK, mTOR and BCL-2 Signal Transduction Inhibition in Acute Lymphoblastic Leukemia (ALL)","display_name":"Multiple Strategies Based on MEK, mTOR and BCL-2 Signal Transduction Inhibition in Acute Lymphoblastic Leukemia (ALL)","publication_year":2008,"publication_date":"2008-11-16","ids":{"openalex":"https://openalex.org/W2530856490","doi":"https://doi.org/10.1182/blood.v112.11.5034.5034","mag":"2530856490"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v112.11.5034.5034","doi":"https://doi.org/10.1182/blood.v112.11.5034.5034","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v112.11.5034.5034","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5067656597","display_name":"Maria Rosaria Ricciardi","orcid":"https://orcid.org/0000-0002-8772-3521","observed_orcids":["https://orcid.org/0000-0002-8772-3521"]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Rosaria Ricciardi","raw_affiliation_strings":["Division of Hematology-Dept. of Cellular Biotechnologies and Hematology, University of Rome, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Dept. of Cellular Biotechnologies and Hematology, University of Rome, Rome, Italy","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023749417","display_name":"Samantha Decandia","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Samantha Decandia","raw_affiliation_strings":["Division of Hematology, Department of Cellular Biotechnologies and Hematology, University La Sapienza, Roma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Department of Cellular Biotechnologies and Hematology, University La Sapienza, Roma, Italy","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069218034","display_name":"Sara Santinelli","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Sara Santinelli","raw_affiliation_strings":["Division of Hematology, Department of Cellular Biotechnologies and Hematology, University La Sapienza, Roma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Department of Cellular Biotechnologies and Hematology, University La Sapienza, Roma, Italy","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5077721366","display_name":"Chiara Gregorj","orcid":"https://orcid.org/0000-0003-0789-779X","observed_orcids":["https://orcid.org/0000-0003-0789-779X"]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Chiara Gregorj","raw_affiliation_strings":["Division of Hematology-Dept. of Cellular Biotechnologies and Hematology, University of Rome \u201cLa Sapienza\u201d, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Dept. of Cellular Biotechnologies and Hematology, University of Rome \u201cLa Sapienza\u201d, Rome, Italy","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030922818","display_name":"Fabiana De Cave","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Fabiana De Cave","raw_affiliation_strings":["Division of Hematology-Dept. of Cellular Biotechnologies and Hematology, University of Rome \u201cLa Sapienza\u201d, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Dept. of Cellular Biotechnologies and Hematology, University of Rome \u201cLa Sapienza\u201d, Rome, Italy","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5014966071","display_name":"Maria Cristina Scerpa","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Cristina Scerpa","raw_affiliation_strings":["Division of Hematology-Dept. of Cellular Biotechnologies and Hematology, University of Rome \u201cLa Sapienza\u201d, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Dept. of Cellular Biotechnologies and Hematology, University of Rome \u201cLa Sapienza\u201d, Rome, Italy","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036246648","display_name":"Paola Bergamo","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Paola Bergamo","raw_affiliation_strings":["Medical Oncology A, Regina Elena National Cancer Institute, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology A, Regina Elena National Cancer Institute, Rome, Italy","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5104097745","display_name":"Francesco Libotte","orcid":"https://orcid.org/0000-0001-9050-324X","observed_orcids":["https://orcid.org/0000-0001-9050-324X"]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Francesco Libotte","raw_affiliation_strings":["Division of Hematology, Department of Cellular Biotechnologies and Hematology, University La Sapienza, Roma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Department of Cellular Biotechnologies and Hematology, University La Sapienza, Roma, Italy","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103396823","display_name":"Cinzia De Benedictis","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Cinzia De Benedictis","raw_affiliation_strings":["Division of Hematology, Department of Cellular Biotechnologies and Hematology, University La Sapienza, Roma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology, Department of Cellular Biotechnologies and Hematology, University La Sapienza, Roma, Italy","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103820249","display_name":"Antonella Vitale","orcid":"https://orcid.org/0009-0006-3030-5480","observed_orcids":["https://orcid.org/0009-0006-3030-5480"]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Antonella Vitale","raw_affiliation_strings":["\u201dLa Sapienza\u201d University, Dept. of Cellular Biotechnologies and Hematology, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"\u201dLa Sapienza\u201d University, Dept. of Cellular Biotechnologies and Hematology, Rome, Italy","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045814742","display_name":"Maria Teresa Petrucci","orcid":"https://orcid.org/0000-0003-0688-4882","observed_orcids":["https://orcid.org/0000-0003-0688-4882"]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Maria Teresa Petrucci","raw_affiliation_strings":["Hematology, University La Sapienza, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Hematology, University La Sapienza, Rome, Italy","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022647201","display_name":"Marina Y Konopleva","orcid":"https://orcid.org/0000-0002-9347-2212","observed_orcids":["https://orcid.org/0000-0002-9347-2212"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Marina Konopleva","raw_affiliation_strings":["Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079262854","display_name":"Michael Andreeff","orcid":"https://orcid.org/0000-0002-1144-1958","observed_orcids":["https://orcid.org/0000-0002-1144-1958"]},"institutions":[{"id":"https://openalex.org/I1343551460","display_name":"The University of Texas MD Anderson Cancer Center","ror":"https://ror.org/04twxam07","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1343551460"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Andreeff","raw_affiliation_strings":["Stem Cell Transplantation & Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stem Cell Transplantation & Cellular Therapy, The University of Texas M.D. Anderson Cancer Center, Houston, TX, USA","institution_ids":["https://openalex.org/I1343551460"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5023848359","display_name":"Mich\u00e8le Milella","orcid":"https://orcid.org/0000-0002-3826-5237","observed_orcids":["https://orcid.org/0000-0002-3826-5237"]},"institutions":[{"id":"https://openalex.org/I4387152244","display_name":"Instituto Nazionale Tumori Regina Elena","ror":"https://ror.org/04mgfev69","country_code":"IT","type":"facility","lineage":["https://openalex.org/I4210153126","https://openalex.org/I4387152244"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Michele Milella","raw_affiliation_strings":["Medical Oncology A, Regina Elena National Cancer Institute, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Medical Oncology A, Regina Elena National Cancer Institute, Rome, Italy","institution_ids":["https://openalex.org/I4387152244"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109931276","display_name":"Robert Fo\u00e0","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Robert Foa","raw_affiliation_strings":["Dept. of Cellular Biotechnologies & Hematology, University \u2018Sapienza\u2019, Rome, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dept. of Cellular Biotechnologies & Hematology, University \u2018Sapienza\u2019, Rome, Italy","institution_ids":["https://openalex.org/I861853513"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5000262370","display_name":"Agostino Tafuri","orcid":"https://orcid.org/0000-0001-7911-9263","observed_orcids":["https://orcid.org/0000-0001-7911-9263"]},"institutions":[{"id":"https://openalex.org/I861853513","display_name":"Sapienza University of Rome","ror":"https://ror.org/02be6w209","country_code":"IT","type":"education","lineage":["https://openalex.org/I861853513"]}],"countries":["IT"],"is_corresponding":false,"raw_author_name":"Agostino Tafuri","raw_affiliation_strings":["Division of Hematology-Dept. of Cellular Biotechnologies and Hematology, University La Sapienza, Roma, Italy"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Hematology-Dept. of Cellular Biotechnologies and Hematology, University La Sapienza, Roma, Italy","institution_ids":["https://openalex.org/I861853513"]}]}],"institutions":[],"countries_distinct_count":2,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"112","issue":"11","first_page":"5034","last_page":"5034"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10950","display_name":"Acute Lymphoblastic Leukemia research","score":0.9872999787330627,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10952","display_name":"PI3K/AKT/mTOR signaling in cancer","score":0.004600000102072954,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0035000001080334187,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/acute-lymphoblastic-leukemia","display_name":"acute lymphoblastic leukemia","score":0.9980000257492065},{"id":"https://openalex.org/keywords/mek-inhibitors","display_name":"MEK inhibitors","score":0.9539999961853027},{"id":"https://openalex.org/keywords/mtor-inhibition","display_name":"mTOR inhibition","score":0.6600000262260437},{"id":"https://openalex.org/keywords/temsirolimus","display_name":"temsirolimus","score":0.8619999885559082},{"id":"https://openalex.org/keywords/bcl2-inhibitors","display_name":"BCL-2 inhibitor","score":0.75},{"id":"https://openalex.org/keywords/abt-737","display_name":"ABT-737","score":0.9959999918937683},{"id":"https://openalex.org/keywords/raf-mek-erk-pathway","display_name":"Raf/MEK/ERK pathway","score":0.8109999895095825},{"id":"https://openalex.org/keywords/pi3k-akt-mtor-pathway","display_name":"PI3K/AKT/mTOR pathway","score":0.9900000095367432},{"id":"https://openalex.org/keywords/erk1-2-phosphorylation","display_name":"ERK1/2 phosphorylation","score":0.9020000100135803},{"id":"https://openalex.org/keywords/apoptosis","display_name":"apoptosis","score":0.48500001430511475},{"id":"https://openalex.org/keywords/cell-cycle-arrest","display_name":"cell cycle arrest","score":0.921999990940094},{"id":"https://openalex.org/keywords/drug-resistance","display_name":"drug resistance","score":0.7480000257492065},{"id":"https://openalex.org/keywords/relapse","display_name":"relapse","score":0.46399998664855957},{"id":"https://openalex.org/keywords/bh3-mimetics","display_name":"BH3 mimetics","score":0.6140000224113464},{"id":"https://openalex.org/keywords/combination-therapy","display_name":"combination therapy","score":0.46799999475479126}],"concepts":[{"id":"https://openalex.org/C86554907","wikidata":"https://www.wikidata.org/wiki/Q285613","display_name":"PI3K/AKT/mTOR pathway","level":3,"score":0.7268199920654297},{"id":"https://openalex.org/C57074206","wikidata":"https://www.wikidata.org/wiki/Q14197552","display_name":"MAPK/ERK pathway","level":3,"score":0.6437915563583374},{"id":"https://openalex.org/C190283241","wikidata":"https://www.wikidata.org/wiki/Q14599311","display_name":"Apoptosis","level":2,"score":0.5854995250701904},{"id":"https://openalex.org/C29537977","wikidata":"https://www.wikidata.org/wiki/Q188941","display_name":"Cell cycle","level":3,"score":0.5826526880264282},{"id":"https://openalex.org/C62112901","wikidata":"https://www.wikidata.org/wiki/Q189159","display_name":"Cell growth","level":2,"score":0.5588800311088562},{"id":"https://openalex.org/C2779707156","wikidata":"https://www.wikidata.org/wiki/Q5611758","display_name":"Growth inhibition","level":3,"score":0.5536150932312012},{"id":"https://openalex.org/C179464577","wikidata":"https://www.wikidata.org/wiki/Q1632589","display_name":"Jurkat cells","level":4,"score":0.5417786836624146},{"id":"https://openalex.org/C2781249067","wikidata":"https://www.wikidata.org/wiki/Q17142288","display_name":"MEK inhibitor","level":4,"score":0.517171323299408},{"id":"https://openalex.org/C75217442","wikidata":"https://www.wikidata.org/wiki/Q423650","display_name":"Protein kinase B","level":3,"score":0.504073977470398},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.4662799835205078},{"id":"https://openalex.org/C62478195","wikidata":"https://www.wikidata.org/wiki/Q828130","display_name":"Signal transduction","level":2,"score":0.46203047037124634},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.44981130957603455},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.44050803780555725},{"id":"https://openalex.org/C95444343","wikidata":"https://www.wikidata.org/wiki/Q7141","display_name":"Cell biology","level":1,"score":0.3681372404098511},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.23709812760353088},{"id":"https://openalex.org/C55493867","wikidata":"https://www.wikidata.org/wiki/Q7094","display_name":"Biochemistry","level":1,"score":0.1317809522151947},{"id":"https://openalex.org/C2776090121","wikidata":"https://www.wikidata.org/wiki/Q193529","display_name":"T cell","level":3,"score":0.05250367522239685},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.04147651791572571},{"id":"https://openalex.org/C8891405","wikidata":"https://www.wikidata.org/wiki/Q1059","display_name":"Immune system","level":2,"score":0.0}],"mesh":[],"locations_count":2,"locations":[{"id":"doi:10.1182/blood.v112.11.5034.5034","doi":"https://doi.org/10.1182/blood.v112.11.5034.5034","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v112.11.5034.5034","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},{"id":"pmh:oai:iris.uniroma1.it:11573/401396","doi":null,"is_oa":false,"landing_page_url":"http://hdl.handle.net/11573/401396","pdf_url":null,"source":{"id":"https://openalex.org/S4377196107","display_name":"IRIS Research product catalog (Sapienza University of Rome)","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"info:eu-repo/semantics/conferenceObject"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9907000064849854}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2550959716","https://openalex.org/W2558578345","https://openalex.org/W2550385070","https://openalex.org/W7002365017","https://openalex.org/W2588736843","https://openalex.org/W2052468128","https://openalex.org/W2986341305","https://openalex.org/W2522873693","https://openalex.org/W7046271856","https://openalex.org/W7100429573"],"abstract_inverted_index":{"Abstract":[0],"In":[1,382],"spite":[2],"of":[3,15,23,73,91,146,159,169,222,235,243,256,296,331,346,353,365,402,427],"improvements":[4],"in":[5,12,39,79,88,106,119,123,131,156,231,270,275,288,324,339,372,377,394,437,442],"the":[6,13,46,48,51,87,144,147,194,236,240,250,378,400,416],"last":[7],"decade,":[8],"relapses":[9],"still":[10],"occurs":[11],"majority":[14],"ALL":[16,81,107,121,161,271,388],"patients,":[17],"with":[18,164,220,294,335],"a":[19,153,157,165,265,281,336,343,349],"long-term":[20],"survival":[21],"rate":[22],"only":[24,379,412],"30\u201340%.":[25],"Recently,":[26],"small-molecule":[27],"inhibitors":[28],"have":[29,62],"been":[30],"developed":[31],"for":[32,58,113,446],"targeting":[33],"deregulated":[34],"signal":[35,433],"transduction":[36,434],"pathways":[37,53,405],"involved":[38],"proliferation":[40],"and":[41,50,83,176,179,253,274,284,304,327,342,367],"apoptosis.":[42,140],"Current":[43],"evidence":[44],"identifies":[45],"Raf/MEK/ERK,":[47],"PI3K/AKT/mTOR,":[49],"Bcl-2":[52,302,366],"as":[54],"potentially":[55],"relevant":[56],"targets":[57],"therapeutic":[59,444],"intervention.":[60],"We":[61,141,247,316],"previously":[63],"demonstrated":[64],"that":[65,319,387,406,429],"constitutive":[66],"ERK":[67,129],"phosphorylation":[68,130],"is":[69],"an":[70],"independent":[71,330],"predictor":[72],"failure":[74],"to":[75,263,355,396,423],"achieve":[76],"complete":[77],"remission":[78],"adult":[80,326],"(Blood2007;109:5473)":[82],"thus":[84],"we":[85],"evaluated":[86],"vitro":[89],"activity":[90,145,287],"MEK-inhibitors.":[92],"However,":[93],"neither":[94],"PD98059":[95,125],"nor":[96],"PD0325901":[97],"affected":[98],"cell":[99,101,108,136,162,191,223,251,272,409],"growth,":[100],"cycle":[102,137,224,252],"distribution,":[103],"and/or":[104],"apoptosis":[105,227,306,347,393],"lines":[109,273],"(IC50":[110,211],">1":[111],"\u03bcM":[112],"PD0325901).":[114],"These":[115],"results":[116],"were":[117,209],"confirmed":[118],"primary":[120,277,325],"samples,":[122,133,374],"which":[124],"significantly":[126],"(P=0.012)":[127],"inhibited":[128],"8/12":[132],"without":[134],"inducing":[135],"changes":[138],"or":[139],"next":[142],"investigated":[143,249],"mTOR":[148],"inhibitor":[149,418],"Temsirolimus.":[150],"Temsirolimus":[151,244],"displayed":[152],"biphasic":[154],"dose-response":[155],"panel":[158],"different":[160],"lines,":[163],"flat":[166],"curve":[167],"(35\u201355%":[168],"inhibition)":[170],"at":[171,184,239,358],"concentrations":[172,185],"ranging":[173],"between":[174],"1":[175],"5,000":[177],"nM":[178,360],"more":[180],"pronounced":[181],"growth":[182,216],"inhibition":[183,217,221],"\u2265":[186],"10":[187,276,359],"\u03bcM.":[188],"The":[189,411],"CEM":[190,309],"line":[192],"was":[193,218,229,321,370,415],"most":[195],"sensitive":[196,373],"(IC50:":[197,204,290,313],"7":[198],"nM),":[199,206,292],"Jurkat":[200],"showed":[201,280],"intermediate":[202],"sensitivity":[203],"200":[205],"while":[207,226],"MOLT-4":[208,289],"resistant":[210,312,380],">":[212],"20,000":[213],"nM).":[214,315],"Cell":[215],"associated":[219,293],"progression,":[225],"induction":[228,345],"observed":[230,371],"less":[232],"than":[233],"15%":[234],"cells":[237,310],"even":[238],"highest":[241],"concentration":[242],"(20":[245],"\u03bcM).":[246],"then":[248],"apoptotic":[254],"effects":[255],"ABT-737":[257,279,320],"(kindly":[258],"provided":[259],"by":[260],"Abbott":[261],"Laboratories":[262],"A.T.),":[264],"Bcl-2/Bcl-xL":[266,417],"(BH3":[267],"mimetic)":[268],"inhibitor,":[269],"samples.":[278],"potent":[282],"dose-":[283],"time-dependent":[285],"growth-inhibitory":[286],"198":[291],"loss":[295],"mitochondrial":[297],"membrane":[298],"potential,":[299],"caspase":[300],"activation,":[301],"cleavage,":[303],"ultimately":[305],"induction.":[307],"Conversely,":[308],"proved":[311],"12,000":[314],"also":[317],"found":[318],"highly":[322],"effective":[323],"childhood":[328],"ALL,":[329],"their":[332],"chromosomal":[333],"abnormalities,":[334],"significant":[337],"decrease":[338],"viability":[340],"(p=0.008)":[341],"remarkable":[344],"(from":[348],"mean":[350],"baseline":[351],"value":[352],"16.8\u00b18.8%":[354],"43.6\u00b122.8%,":[356],"p=0.04)":[357],"ABT-737.":[361,419],"A":[362],"dose-dependent":[363],"down-regulation":[364],"Bcl-xL":[368],"expression":[369],"but":[375],"not":[376,391],"one.":[381],"summary,":[383],"our":[384],"study":[385],"shows":[386],"cells,":[389],"do":[390],"undergo":[392],"response":[395],"single-pathway":[397],"inhibition,":[398],"suggesting":[399],"presence":[401],"multiple,":[403],"redundant":[404],"preserve":[407],"leukemic":[408],"survival.":[410],"notable":[413],"exception":[414],"Studies":[420],"are":[421],"ongoing":[422],"identify":[424],"mechanism-driven":[425],"combinations":[426],"agents":[428],"would":[430],"disrupt":[431],"multiple":[432],"pathways,":[435],"resulting":[436],"synergistic":[438],"killing":[439],"and,":[440],"ultimately,":[441],"novel":[443],"strategies":[445],"ALL.":[447]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-10-21T00:00:00"}